The 2007 peer-reviewed confirmation of GHK-Cu's direct hair growth promotion in human tissue, combined with the extensive evidence on follicle enlargement, anagen extension, and scalp angiogenesis, makes GHK-Cu one of the most biologically rational approaches to hair loss available in 2026
I have so much energy after I take it
New England Journal of Medicine (2025) The REDEFINE 1 Phase 3 trial was a landmark 68-week, double-blind, randomized study comparing CagriSema (cagrilintide 2.4 mg plus semaglutide 2.4 mg) with semaglutide alone, cagrilintide alone, and placebo in 3,417 adults with obesity or overweight without diabetes
Milly TA, Tal-Gan Y (2023) Targeting peptide-based quorum sensing systems for the treatment of Gram-positive bacterial infections
its also about creating a healthier scalp environment